Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

910.69 -9.05 (-0.98%)
Official Closing Price Updated: 7:00 PM EDT, Oct 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,682,055
Open 920.00
Bid (Size) 910.11 (1)
Ask (Size) 912.00 (2)
Prev. Close 919.74
Today's Range 905.15 - 922.00
52wk Range 547.61 - 972.53
Shares Outstanding N/A
Dividend Yield 0.50%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
FTC Faces Pressure to Block Novo Nordisk-Catalent Merger Over Antitrust Fears
Concerns are rising as Novo Nordisk's $16.5 billion bid to acquire Catalent faces scrutiny from the FTC. Critics argue the merger could harm competition in the GLP-1 market, potentially driving up... 
Via Benzinga
Eli Lilly Issues Cease-And-Desist Letters to Compounders Over Weight-Loss Drug Copies As Shortage Resolves
Eli Lilly intensifies its legal efforts against compounding pharmacies producing copycat versions of its weight-loss drugs, Mounjaro and Zepbound, after the FDA declares the tirzepatide shortage... 
Via Benzinga
Exposures Product Safety

Performance

YTD
+53.78%
+53.78%
1 Month
+1.05%
+1.05%
3 Month
-2.51%
-2.51%
6 Month
+19.89%
+19.89%
1 Year
+50.46%
+50.46%

More News

Read More
2 No-Brainer Dividend Growth Stocks to Buy Right Now
Via The Motley Fool
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
Via Benzinga
(LLY) - Analyzing Eli Lilly's Short Interest
Via Benzinga
Evaluating Eli Lilly Against Peers In Pharmaceuticals Industry
Via Benzinga
CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit
Via Benzinga
What's Going With WeightWatchers Stock On Wednesday?
Via Benzinga
Exposures Product Safety
Don’t Sleep on Skye Bioscience—This Weight Loss Drug Could Soar
Via MarketBeat
Why Eli Lilly Was Such a Healthy Stock Today
Via The Motley Fool
FDA Sparks Controversy With Sudden Removal Of Eli Lilly's Weight Loss Drug From Shortage List
Via Benzinga
Exposures Product Safety
Hims & Hers Stock Joins S&P 600: Is More Upside on the Horizon?
Via MarketBeat
Topics Stocks
Exposures US Equities
With Its GLP-1 Drugs No Longer in a Shortage, Is Now the Time to Buy Eli Lilly Stock?
Via The Motley Fool
UNH: A Solid Healthcare Play In A Rotational Market
Via Talk Markets
Billion-Dollar News for Eli Lilly Stock Investors
Via The Motley Fool
Biotech Stocks Poised For Another Big Move In Q4
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Regeneron Chief Flags Health Risks with Popular Weight-Loss Medications Like Ozempic, Says Company Targets Muscle Preservation For Its Obesity Drugs
Via Benzinga
2 Next-Gen Weight Loss Stocks That Are Worth Buying Right Now
Via The Motley Fool
Economist Justin Wolfers Points To Obesity Rate Decline As Ozempic And Wegovy Spur Historic Shift In Fight Against Obesity — Has US Reached A Turning Point?
Via Benzinga
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades
Via The Motley Fool
Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages
Via Benzinga
Exposures Product Safety
England's NHS Proposes Phased Rollout of Eli Lilly's Mounjaro, Considers Digital Services to Boost Access
Via Benzinga
As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer
Via Investor's Business Daily
Massive News for Hims & Hers Stock: The Truth About Today's Move
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.